| 1 |
polycystic ovary syndrome
(13122 times)
|
Endocrinology
(3203 times)
|
BMI (1528 times)
IR (718 times)
LH (689 times)
|
1978 Pituitary response to bolus and continuous intravenous infusion of luteinizing hormone-releasing factor in normal women and women with polycystic ovarian syndrome.
|
| 2 |
PCOS group
(18 times)
|
Obstetrics
(6 times)
|
FSH (4 times)
LH (4 times)
BMI (3 times)
|
1997 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
|
| 3 |
polycystic ovarian disease
(10 times)
|
Reproductive Medicine
(4 times)
|
AMPK (1 time)
AN (1 time)
aOR (1 time)
|
1987 Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels.
|
| 4 |
Prostate Cancer Care and Outcomes Study
(5 times)
|
Medicine
(3 times)
|
ADT (1 time)
CAMs (1 time)
HRQoL (1 time)
|
2011 Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.
|
| 5 |
Prostate Cancer Outcomes Study
(5 times)
|
Urology
(3 times)
|
CI (3 times)
CEASAR (1 time)
OR (1 time)
|
2000 Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study.
|
| 6 |
PCO syndrome
(3 times)
|
Endocrinology
(2 times)
|
PCO (2 times)
AD (1 time)
EGF (1 time)
|
1990 Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles.
|
| 7 |
PCOS-d
(2 times)
|
Endocrinology
(2 times)
|
AMH (1 time)
NW-g (1 time)
|
2016 Evidence for Increased 5alpha-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.
|
| 8 |
polycystic ovarian disease syndrome
(2 times)
|
Genetics
(1 time)
|
AA (1 time)
COX (1 time)
GDF15 (1 time)
|
2013 Gene bionetworks that regulate ovarian primordial follicle assembly.
|
| 9 |
groups: control;polycystic ovary syndrome
(1 time)
|
Biochemistry
(1 time)
|
ADM (1 time)
ATF6 (1 time)
Bcl-2 (1 time)
|
2021 Potential effect of adrenomedullin on metabolic and endocrinal dysfunctions in the experimentally induced polycystic ovary: Targeting implication of endoplasmic reticulum stress.
|
| 10 |
IV-polycystic ovariorum syndrome
(1 time)
|
Gynecology
(1 time)
|
ACA (1 time)
aPL (1 time)
APTT (1 time)
|
2000 [Antiphospholipid autoantibodies in women treated for infertility].
|
| 11 |
non-PCOS groups did not differ significantly
(1 time)
|
|
HOMA-IR (1 time)
LGI (1 time)
|
2019 Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
|
| 12 |
palliative care order set
(1 time)
|
Health Services
(1 time)
|
CMO (1 time)
|
2011 Impact of standardized palliative care order set on end-of-life care in a community teaching hospital.
|
| 13 |
parameters were comparable between Fathers
(1 time)
|
Endocrinology
(1 time)
|
BMI (1 time)
FGI (1 time)
FI (1 time)
|
2003 Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
|
| 14 |
Patient-Centered Outcomes Spectrum
(1 time)
|
General Surgery
(1 time)
|
EGS (1 time)
|
2017 Patient-Centered Outcome Spectrum: An Evidence-based Framework to Aid in Shared Decision-making.
|
| 15 |
patients about their condition
(1 time)
|
Public Health
(1 time)
|
---
|
2008 Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome.
|
| 16 |
patients with micropolycystic ovary syndrome
(1 time)
|
Endocrinology
(1 time)
|
---
|
1988 Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome.
|
| 17 |
PCO rats
(1 time)
|
Endocrinology
(1 time)
|
PCO-SON rats (1 time)
SON (1 time)
|
2018 Sympathetic innervation regulates macrophage activity in rats with polycystic ovary.
|
| 18 |
PCO Scale
(1 time)
|
Education
(1 time)
|
J-PCOS (1 time)
PCO (1 time)
|
2021 Translating and validating a Japanese version of the Patient Care Ownership Scale: a multicenter cross-sectional study.
|
| 19 |
PCOS compared to controls
(1 time)
|
Endocrinology
(1 time)
|
FMD (1 time)
IMT (1 time)
NID (1 time)
|
2006 Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
|
| 20 |
PCOS group, PCOSG
(1 time)
|
Gynecology
(1 time)
|
QoL (1 time)
RET (1 time)
|
2016 Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training.
|
| 21 |
PCOS only
(1 time)
|
Internal Medicine
(1 time)
|
FMD (1 time)
|
2017 Association between polycystic ovary syndrome and the risk of subclinical vascular disease in normal‑weight women with type 1 diabetes.
|
| 22 |
PCOS patients during the proliferative phase
(1 time)
|
Molecular Biology
(1 time)
|
EMT (1 time)
MAPK (1 time)
nPCOS (1 time)
|
2020 Alterations of endometrial epithelial-mesenchymal transition and MAPK signalling components in women with PCOS are partially modulated by metformin in vitro.
|
| 23 |
PCOS receiving no treatment
(1 time)
|
Endocrinology
(1 time)
|
IL (1 time)
SISAF (1 time)
TNF (1 time)
|
2019 Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycine max L. Merrill) in rats with estradiol valerate-induced polycystic ovary syndrome as an inflammatory state.
|
| 24 |
PCOS women
(1 time)
|
Endocrinology
(1 time)
|
FMD (1 time)
IMT (1 time)
NID (1 time)
|
2006 Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
|
| 25 |
PCOS-Anov
(1 time)
|
Endocrinology
(1 time)
|
AGEs (1 time)
AMH (1 time)
Non-PCOS Anov (1 time)
|
2009 Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
|
| 26 |
PCOS-EVs
(1 time)
|
Endocrinology
(1 time)
|
CAT (1 time)
EVs (1 time)
GSS (1 time)
|
2022 Inhibition of oocyte maturation by follicular extracellular vesicles of non-hyperandrogenic PCOS patients requiring IVF.
|
| 27 |
PCOS-noPM
(1 time)
|
Endocrinology
(1 time)
|
CI (1 time)
OR (1 time)
PM (1 time)
|
2021 The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
|
| 28 |
PCOS-SNPs
(1 time)
|
Reproductive Medicine
(1 time)
|
C9orf3 (1 time)
DENND1A (1 time)
GWAS (1 time)
|
2015 Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
|
| 29 |
PCOSEs
(1 time)
|
Reproductive Medicine
(1 time)
|
SHBG (1 time)
|
2006 Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome.
|
| 30 |
pellets containing DHT
(1 time)
|
Endocrinology
(1 time)
|
DHT (1 time)
EA (1 time)
GLUT4 (1 time)
|
2010 Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
|
| 31 |
physiopathological condition
(1 time)
|
Medicine
(1 time)
|
IR (1 time)
LEP (1 time)
|
2004 [Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance].
|
| 32 |
PLGA-coated-only stents
(1 time)
|
Cardiology
(1 time)
|
BMS (1 time)
PCSES (1 time)
PLGA (1 time)
|
2009 Long-term effects of novel biodegradable, polymer-coated, sirolimus-eluting stents on neointimal formation in a porcine coronary model.
|
| 33 |
policistico
(1 time)
|
Gynecology
(1 time)
|
ALA (1 time)
|
2020 [Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome].
|
| 34 |
polycystic
(1 time)
|
Physiology
(1 time)
|
BMI (1 time)
NC (1 time)
PC (1 time)
|
2022 Effect of sodium alginate supplementation on weight management and reproductive hormones in polycystic females.
|
| 35 |
Polycystic ovarian, or stein leventhal, syndrome
(1 time)
|
Fertility
(1 time)
|
AFM (1 time)
CZ (1 time)
IL-18 (1 time)
|
2023 Silver Nanoparticles Biofabricated from Cinnamomum zeylanicum Reduce IL-6, IL-18, and TNF-ɑ in Female Rats with Polycystic Ovarian Syndrome.
|
| 36 |
Polycystic Ovary Syndrome women
(1 time)
|
Biochemistry
(1 time)
|
OAT (1 time)
OATP (1 time)
WB (1 time)
|
2015 Expression of steroid sulfated transporters and 3beta-HSD activity in endometrium of women having polycystic ovary syndrome.
|
| 37 |
Polycystic syndrome
(1 time)
|
Gynecology
(1 time)
|
---
|
2012 Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.
|
| 38 |
population/s was mostly represented by hyperhomocysteinemia in both the cohorts
(1 time)
|
Reproductive Medicine
(1 time)
|
---
|
2022 Significance of Hyperhomocysteinemia in Immediate As Well As Long-Term Health Risk/s in Women with Polycystic Ovary Syndrome: a Probabilistic Model Using Dynamic Bayesian Network Analysis.
|
| 39 |
posterior circulation stroke
(1 time)
|
Brain
(1 time)
|
TVSs (1 time)
|
2021 Transient Vestibular Symptoms Preceding Posterior Circulation Stroke: A Prospective Multicenter Study.
|
| 40 |
potential (CCL2, IL-6, ORM1, TNAIFP6, SFRP4, SPARC). eSF
(1 time)
|
Endocrinology
(1 time)
|
eEPs (1 time)
eSFs (1 time)
|
2013 Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
|
| 41 |
pregnancy hypertension
(1 time)
|
Reproductive Medicine
(1 time)
|
aRRs (1 time)
ART (1 time)
CIs (1 time)
|
2022 Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis.
|
| 42 |
prooncogenic changes, independent of body mass index, especially in eEP
(1 time)
|
Endocrinology
(1 time)
|
eEPs (1 time)
eSFs (1 time)
|
2013 Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
|
| 43 |
Prospective study of age-matched, nonpolycystic ovary syndrome
(1 time)
|
Infertility
(1 time)
|
DHEAS (1 time)
FF (1 time)
IVF (1 time)
|
2016 Follicular fluid dehydroepiandrosterone sulfate is a credible marker of oocyte maturity and pregnancy outcome in conventional in vitro fertilization cycles.
|
| 44 |
purified COS products
(1 time)
|
Carbohydrates
(1 time)
|
COS (1 time)
DP (1 time)
HLP (1 time)
|
2017 Enzymatic single-step preparation and antioxidant activity of hetero-chitooligosaccharides using non-pretreated housefly larvae powder.
|
| 45 |
pyrolyzed crushed oyster shells
(1 time)
|
Environmental Health
(1 time)
|
ORP (1 time)
|
2022 Field study on short-term changes in benthic environment and benthic microbial communities using pyrolyzed oyster shells.
|
| 46 |
registries-Prostate Cancer Outcomes Study
(1 time)
|
Neoplasms
(1 time)
|
CaPSURE (1 time)
CPDR (1 time)
PSA (1 time)
|
2004 Prostate cancer 2004: insights from national disease registries.
|
A Search Service for Abbreviation / Long Form